RXORXO
Market Cap: $3.14B
About: RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the largest component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement our truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operating segment operate within the transportation industry and in primarily the same geography North America.
Employees: 8,432
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
50% more funds holding in top 10
Funds holding in top 10: 4 [Q1] → 6 (+2) [Q2]
22% more capital invested
Capital invested by funds: $2.57B [Q1] → $3.15B (+$577M) [Q2]
14% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 28
11% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 75
1.93% more ownership
Funds ownership: 100.34% [Q1] → 102.27% (+1.93%) [Q2]
2% more funds holding
Funds holding: 237 [Q1] → 241 (+4) [Q2]
92% less call options, than puts
Call options by funds: $1.22M | Put options by funds: $14.6M
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
9 analyst ratings
Susquehanna Bascome Majors 59% 1-year accuracy 26 / 44 met price target | 25%downside $20 | Negative Maintained | 15 Aug 2024 |
Jefferies Stephanie Moore 62% 1-year accuracy 8 / 13 met price target | 16%upside $31 | Buy Maintained | 13 Aug 2024 |
Morgan Stanley Ravi Shanker 36% 1-year accuracy 13 / 36 met price target | 3%downside $26 | Equal-Weight Maintained | 12 Aug 2024 |
TD Cowen Jason Seidl 53% 1-year accuracy 9 / 17 met price target | 5%upside $28 | Hold Maintained | 8 Aug 2024 |
JP Morgan Brian Ossenbeck 50% 1-year accuracy 23 / 46 met price target | 3%downside $26 | Underweight Maintained | 8 Aug 2024 |
Financial journalist opinion
Based on 7 articles about RXO published over the past 30 days